Table 2. Correlation of tsRNA-5001a expression with clinicopathological characteristics determined by Pearson’s correlation analysis.
| Parameters | tsRNA-5001a expression | |
|---|---|---|
| R | P value | |
| DFS | −0.432 | 0.003a |
| OS | −0.340 | 0.024 |
| Gender (male/female) | 0.296 | 0.051 |
| Age | −0.298 | 0.049 |
| TNM stage (IA-IIA/IIB and above) | 0.325 | 0.031 |
| Solid type (yes/no) | −0.147 | 0.34 |
| Micropapillary (yes/no) | −0.058 | 0.707 |
| Smoking status (yes/no) | 0.165 | 0.284 |
| EGFR mutation (19del/21L858R) | −0.271 | 0.075 |
a, P<0.05 was considered statistically significant. DFS, disease-free survival; OS, overall survival; EGFR, epidermal growth factor receptor; TNM stage, tumor-node-metastasis stage.